Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Por um escritor misterioso
Descrição
Ibrutinib Single-handedly Impacts Immune Environment in Metastatic PDAC
Genes, Free Full-Text
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Pharmaceutics, Free Full-Text
Role of myeloid-derived suppressor cells in tumor recurrence
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers - Ren - 2023 - MedComm - Wiley Online Library
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets, Journal of Hematology & Oncology
Frontiers Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy, Biomarker Research
Current and Evolving Therapies for Metastatic Pancreatic Cancer: Are We Stuck With Cytotoxic Chemotherapy?
de
por adulto (o preço varia de acordo com o tamanho do grupo)
